Related references
Note: Only part of the references are listed.Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma
Y. W. Sun et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer
Ren Chong Xi et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer
Niels Fristrup et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort
Praveen Kumar Jaiswal et al.
MOLECULAR BIOLOGY REPORTS (2012)
Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder
Oliver Patschan et al.
WORLD JOURNAL OF UROLOGY (2012)
ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder Cancer
Fumitaka Koga et al.
PLOS ONE (2011)
Detection of Nuclear Matrix Protein 22 and Survivin Baseline Level in Patients after Radical Cystectomy
Zhi-Long Dong et al.
UROLOGIA INTERNATIONALIS (2011)
Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer
Angela Gradilone et al.
BJU INTERNATIONAL (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles
Marc Birkhahn et al.
EUROPEAN UROLOGY (2010)
Cyclooxygenase-2 and Survivin in Superficial Urothelial Carcinoma of the Bladder and Correlation with Intratumoural Microvessel Density
U. Yildirim et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2010)
Genoproteomic Mining of Urothelial Cancer Suggests γ-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy
Courtney Pollard et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
P. de Graeff et al.
BRITISH JOURNAL OF CANCER (2009)
Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study
Shahrokh F. Shariat et al.
CLINICAL CANCER RESEARCH (2009)
SURVIVIN EXPRESSION AS A PREDICTIVE MARKER FOR LOCAL CONTROL IN PATIENTS WITH HIGH-RISK T1 BLADDER CANCER TREATED WITH TRANSURETHRAL RESECTION AND RADIOCHEMOTHERAPY
Christian Weiss et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2009)
Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer
Yaser Atlasi et al.
CANCER DETECTION AND PREVENTION (2009)
Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder
Samia Gonzalez et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Targeting survivin in cancer therapy
Marzia Pennati et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Survivin: a promising biomarker for detection and prognosis of bladder cancer
Vitaly Margulis et al.
WORLD JOURNAL OF UROLOGY (2008)
Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder
Shahrokh F. Shariat et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas
L. Pina-Cabral et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2007)
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder
Jose A. Karam et al.
UROLOGY (2007)
Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer
Wang Yanbo et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2007)
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
Anne B. Als et al.
CLINICAL CANCER RESEARCH (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality
Shahrokh F. Shariat et al.
CANCER (2007)
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder
Vitaly Margulis et al.
JOURNAL OF UROLOGY (2007)
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma
Iman J. Schultz et al.
EUROPEAN UROLOGY (2007)
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
Jose A. Karam et al.
LANCET ONCOLOGY (2007)
The p53 pathway and outcome among patients with T1G3 bladder tumors
Elena Lopez-Knowles et al.
CLINICAL CANCER RESEARCH (2006)
Survivin study: An update of What is the next wave?
Fengzhi Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Meta-analysis when only the median survival times are known: A comparison with individual patient data results
S Michiels et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis
S Weikert et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer
F Rödel et al.
CANCER RESEARCH (2005)
Nuclear or cytoplasmic expression of survivin: What is the significance?
FZ Li et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder
JH Ku et al.
JOURNAL OF UROLOGY (2004)
The expression and significance of survivin mRNA in urinary bladder carcinomas
HD Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas
IJ Schultz et al.
CLINICAL CHEMISTRY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome
DA Hausladen et al.
JOURNAL OF UROLOGY (2003)
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer
P Gazzaniga et al.
ANNALS OF ONCOLOGY (2003)
Aggregate data meta-analysis with time-to-event outcomes
PR Williamson et al.
STATISTICS IN MEDICINE (2002)
Prognostic factors in breast cancer: Current and new predictors of metastasis
DF Hayes et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
Share Paper
